Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
US10011612B2 · kind B2 · utility
21Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2016 |
| Grant date | Jul 3, 2018 |
| Priority date | — |
| Expiry date | Aug 25, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an aryl, heteroaryl or heterocycle (R32) are provided. The inhibitors of Factor D described herein reduce the excessive activation of complement.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.